ERNA vs. SPPL
ERNA (Eterna Therapeutics Inc) and SPPL (SIMPPLE LTD. Ordinary Shares) are both stocks. ERNA operates in Biotechnology (Healthcare), while SPPL operates in Software - Application (Technology). Over the past year, ERNA returned -91.59% vs 23.50% for SPPL. Their 0.05 correlation means their historical movements had little consistent relationship.
Performance
ERNA vs. SPPL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ERNA achieves a -89.07% return, which is significantly lower than SPPL's -18.35% return.
ERNA
- 1D
- -5.48%
- 1M
- -47.69%
- 6M
- -89.25%
- YTD
- -89.07%
- 1Y
- -91.59%
- 3Y*
- -85.19%
- 5Y*
- -86.94%
- 10Y*
- -64.30%
- ALL TIME*
- -33.20%
SPPL
- 1D
- 4.52%
- 1M
- -0.29%
- 6M
- 6.77%
- YTD
- -18.35%
- 1Y
- 23.50%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -56.91%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $350.09K | $8.77M | $15.38M | |
| $171.68K | $190.42K | $3.56M |
ERNA vs. SPPL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
ERNA Eterna Therapeutics Inc | -89.07% | -72.79% | -83.62% | -18.22% |
SPPL SIMPPLE LTD. Ordinary Shares | -18.35% | -46.88% | -83.08% | 20.61% |
Correlation
The correlation between ERNA and SPPL is -0.02, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.02 |
Correlation (All Time) Calculated using the full available price history since Sep 13, 2023 | 0.05 |
Fundamentals
ERNA:
$1.03M
SPPL:
$16.91M
ERNA:
-$23.80
SPPL:
-SGD 1.34
ERNA:
0.38
SPPL:
7.51
ERNA:
$0.00
SPPL:
SGD 8.82M
ERNA:
-$69.00K
SPPL:
SGD 4.79M
ERNA:
-$11.25M
SPPL:
-SGD 7.00M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ERNA vs. SPPL — Risk / Return Rank
ERNA
SPPL
ERNA vs. SPPL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Eterna Therapeutics Inc (ERNA) and SIMPPLE LTD. Ordinary Shares (SPPL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ERNA | SPPL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.79 | ||
| Sortino ratioReturn per unit of downside risk | -2.54 | ||
| Omega ratioGain probability vs. loss probability | 0.82 | 1.12 | -0.30 |
| Calmar ratioReturn relative to maximum drawdown | -0.99 | 0.24 | -1.24 |
| Martin ratioReturn relative to average drawdown | -1.47 | 0.39 | -1.87 |
Loading charts...
Drawdowns
ERNA vs. SPPL - Drawdown Comparison
The maximum ERNA drawdown since its inception was -100.00%, roughly equal to the maximum SPPL drawdown of -97.62%. Use the drawdown chart below to compare losses from any high point for ERNA and SPPL.
Loading charts...
Drawdown Indicators
| ERNA | SPPL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -97.62% | -2.38% |
Max Drawdown (1Y)Largest decline over 1 year | -93.02% | -72.81% | -20.21% |
Max Drawdown (3Y)Largest decline over 3 years | -99.70% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -100.00% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | — | — |
Current DrawdownCurrent decline from peak | -100.00% | -95.41% | -4.59% |
Average DrawdownAverage peak-to-trough decline | -86.20% | -81.91% | -4.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 62.71% | 44.83% | +17.88% |
Volatility
ERNA vs. SPPL - Volatility Comparison
Eterna Therapeutics Inc (ERNA) has a higher volatility of 35.09% compared to SIMPPLE LTD. Ordinary Shares (SPPL) at 18.86%. This indicates that ERNA's price experiences larger fluctuations and is considered to be riskier than SPPL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ERNA | SPPL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 35.09% | 18.86% | +16.23% |
Volatility (6M)Calculated over the trailing 6-month period | 132.84% | 64.33% | +68.51% |
Volatility (1Y)Calculated over the trailing 1-year period | 154.51% | 93.76% | +60.75% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 114.04% | 201.53% | -87.49% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 149.29% | 201.53% | -52.24% |
Dividends
ERNA vs. SPPL - Dividend Comparison
Neither ERNA nor SPPL has paid dividends to shareholders.
Financials
ERNA vs. SPPL - Financials Comparison
This section allows you to compare key financial metrics between Eterna Therapeutics Inc and SIMPPLE LTD. Ordinary Shares. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ERNA and SPPL have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ERNA has higher volatility (35.09%) compared to SPPL (18.86%). In terms of maximum drawdown, ERNA dropped -100.00% vs SPPL's -97.62%.
SPPL currently has the higher Sharpe Ratio (0.19 vs -0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ERNA and SPPL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer